Supplementary Materials for
Robust deep learning‚Äìbased protein sequence design using ProteinMPNN
J. Dauparas et al.
Corresponding author: D. Baker, dabaker@uw.edu
Science 378, 49 (2022)
DOI: 10.1126/science.add2187

The PDF file includes:
Materials and Methods
Figs. S1 to S12
Table S1
References

Materials and Methods
Methods for training single chain models
Training data
For single chain experiments presented in Table 1 we used a set of 19.7k high resolution
single-chain structures from the PDB were split into train, validation and test sets (80/10/10)
based on the CATH4.2 40% non-redundant set of proteins (1, 8). We trained models
following the setup described in (1), i.e. using the learning rate schedule and initialization of
the original Transformer paper (22), a dropout rate of 10% (23), a label smoothing rate of
10% (24), batch size with 6000 tokens, graph sparsity was set to be 30 nearest neighbors
using CŒ±-CŒ± distances.
Architecture modifications
For experiment 1 we added extra input edge features, namely 16 Gaussian radial basis
functions (RBFs) equally spaced from 0 √Ö to 20 √Ö for distances between N, CŒ±, C, O, and
virtual CŒ≤ for i and j residues. This resulted in 25*16=400 edge features. The virtual CŒ≤
coordinates were calculated using ideal angle and bond length definitions: b = CŒ± - N, c = C
- CŒ±, a = cross(b, c), CŒ≤ = -0.58273431*a + 0.56802827*b - 0.54067466*c + CŒ±.
For experiment 2 we introduced edge updates for the encoder network. The inputs to the
encoder are node (denoted Vi) and edge (denoted Eij) features for i and j residues. A
message Mij is constructed using a multilayer perceptron (MLP) applied to [Vi, Vj, Eij]
concatenated tensors. These messages are summed over neighbors, j, and an additional
MLP is applied to get a new updated nodes Vinew. These new nodes are used to get new
edges, Eijnew=MLP[Vinew, Vjnew, Eij]. We used layer normalization, dropout, and residual
connections for all layers, hnew = LayerNorm[hold + Dropout(dh)], where dh is an output from
the layer, hold is the old value, hnew is the updated new value.
For experiment 4 we implemented a random decoding order when training. To achieve this
we constructed a random permutation matrix on-the-fly for every input example and applied
it to rows and columns of the upper triangular matrix which is an autoregressive mask for the
left to right decoding. Alternatively, one could permute input tokens and keep the

2

autoregressive mask fixed given that the neural network architecture is permutation
equivariant which is the case for most graph neural networks.
Methods for training multichain models
Training data
We trained ProteinMPNN on protein assemblies in the PDB (as of Aug 02, 2021) determined
by X-ray crystallography or cryoEM to better than 3.5 √Ö resolution and with less than 10,000
residues. Sequences were clustered at 30% sequence identity cutoff using mmseqs2 (25)
resulting in 25,361 clusters. We split those clusters randomly into three groups for training
(23,358), validation (1,464), and testing (1,539), ensuring that none of the chains from the
target chain or chains from the biounits of the target chain would be in the other two groups.
Every training epoch, we cycled through the sequence clusters and picked a random
sequence member from each cluster, and for each such ‚Äòquery' we randomly picked a
protein conformation (in cases where there were multiple) and reconstructed the biological
assembly for the corresponding PDB entry; for cases with multiple biological assemblies, we
picked one assembly at random. For hetero-oligomeric assemblies, we masked out the
sequence from the query chain but provided the network with the sequence information on
all other chains in the assembly, while for homo-oligomers, sequences were masked out
from all copies to prevent potential information leakage (two protein chains were considered
as homo-oligomeric if the sequence identity between residues aligned by TM-align (26) was
higher than 70%.
Loss function and optimization
We used negative log likelihood with a label smoothing rate of 10% (24) for the loss (not
using label smoothing works well too). The sum of negative probabilities worked much better
than the average of log probabilities. The training loss was defined by lossaverage = sum(loss *
mask) / 2000 where 2000 was chosen empirically, loss (categorical cross entropy per token)
and mask had shapes [batch, protein length]. For optimization we used Adam with beta1 =
0.9, beta2 = 0.98, epsilon= 10‚àí9, and the learning rate schedule described in (22). Models
were trained using pytorch (27), batch size of 10k tokens, automatic mixed precision, and
gradient checkpointing on a single NVIDIA A100 GPU. Training and validation losses
(perplexities) as functions of optimizer steps are shown in Figure S3D. Validation loss
converged after about 150k optimizer steps which is about 100 epochs of on-the-fly sampled
training data from 23,358 PDB clusters.
3

Input features
ProteinMPNN input features were just embedded edges without any node features (Figure
1A). Using protein dihedral angles as node input features did not result in better performance
so for simplicity in dealing with multichain backbones we did not use any node input
features. The edge features consisted of distances between residues in Euclidean space
and distances between residues in the primary sequence space (relative positional
encoding) within a chain plus an indicator if residues are in different chains. We encoded
distances between N, CŒ±, C, O, and virtual CŒ≤ (see Methods for training single chain models
for the definition of CŒ≤) for i and j residues using 16 RBFs equally spaced from 2√Ö to 22√Ö.
For relative positional encoding we used AlphaFold-like (10) discrete (one-hot encoded)
tokens -32, -31,..., 31, 32 within the protein chains and additional token 33 if residues are in
different chains. Ablating positional encodings showed almost the same performance
suggesting that relative primary sequence or inter-chain information is already present in the
Euclidean distances between atoms, e.g. distances between neighboring CŒ± atoms are the
same for all residues.
Model architecture
We used encoder-decoder message passing neural networks for this task (1, 22, 28), see
Figure 1. The encoder takes graph nodes and edges as inputs and using 3 layers with
hidden dimension of 128 (larger hidden dimensions mainly decrease training loss with only
marginal gains to the validation loss) updates those nodes and edges using message
passing with edge updates.
Pseudocode for the encoder layer (V - node features, E - edge features):
def encoder_layer_forward(V, E):
M_ij = MLP[V_i, V_j, E_ij]
dV_i = Sum_j [M_ij]
V_i = LayerNorm[V_i + Dropout(dV_i)]
dV_i = FeedForward[V_i]
V_i = LayerNorm[V_i + Dropout(dV_i)]
dE_ij = MLP[V_i, V_j, E_ij]
E_ij = LayerNorm[E_ij + Dropout(dE_ij)]
return V, E

4

The decoder takes in node and edge features from the encoder plus encoded protein
sequence to which an autoregressive mask is applied. The decoder layer is a vanilla MPNN
layer with 3 layers and 128 hidden dimensions.
Pseudocode for the decoder layer (V - node features, E - edge features, S - sequence
features, mask - autoregressive mask):
def decoder_layer_forward(V, E, S, mask):
E_ij = Concat[E_ij, S_j] * mask_ij + Concat[E_ij, 0.0*S_j] * (1-mask_ij)
M_ij = MLP[V_i, V_j, E_ij]
dV_i = Sum_j [M_ij]
V_i = LayerNorm[V_i + Dropout(dV_i)]
dV_i = FeedForward[V_i]
V_i = LayerNorm[V_i + Dropout(dV_i)]
return V
For both encoder and decoder the multi-layer perceptrons (MLPs) had 3 linear layers of the
model‚Äôs hidden dimension and GELU activation functions (GELU worked slightly better
compared with ReLU). The FeedForward layers had 2 linear layers with GELU activations
and with the middle hidden dimension 4 times bigger than the input dimension as in the
Transformer paper (22).
Further in silico analysis
Comparing with Rosetta fixed backbone design
For a test set of 402 monomer backbones we found that ProteinMPNN had a much higher
overall native sequence recovery (52.4% vs 32.9%), with improvements across the full range
of residue burial from protein core to surface (Figure 2A). We also found the sequence
recoveries are correlated between Rosetta and ProteinMPNN designs (Figure S12) likely
due to the fact that some backbones have more geometric context that can be used to
predict correct amino acids.
Amino acid compositional bias
Figure S2 shows ProteinMPNN and Rosetta amino acid compositional bias compared with
the native PDB sequences. ProteinMPNN sequences were designed using temperature
5

T=0.1. Rosetta designed sequences have an overrepresentation of alanines in the core and
boundary. Both models favor a negatively charged glutamic acid, E, on the surface and
disfavor a polar amino acid glutamine, Q. Interestingly, ProteinMPNN and Rosetta biases
strongly disagree for lysine, K on the surface. Amino acid bias for ProteinMPNN is a function
of the sampling temperature (see Figure S6) with low temperatures introducing more
charged amino acids on the surface.
AlphaFold benchmarks
We ran all 5 AlphaFold ptm models with 3 recycles and selected the model with the highest
average pLDDT as described in the AlphaFold paper (9) using only a single sequence as an
input. For results described in Figure 2C and Figures S7, S8, S9, we generated 8 sequences
per target backbone for 396 monomers (with maximum length of 300 residues) from the test
set and used AlphaFold to predict structures for these sequences. Dependence on the
inference noise level and sampling temperature for sequence recovery and relative
AlphaFold success rate for the MPNN model trained with 0.2√Ö are shown in Figure S7A, B.
Both of these metrics decrease with higher levels of noise and temperature. We also
generated 8 sequences per target backbone for 277 homomers (with maximum length of
400 residues) and plotted sequence recovery and inter-chain predicted aligned error (PAE)
as a function of the MPNN training noise level, Figure S7C. The trend is very much the same
as for the monomer case showing that sequences from slightly noised MPNN models are
more easily decoded by AlphaFold. It is important to notice that AlphaFold success rate for
the single sequence prediction depends on the number of recycles used during the
inference. We benchmarked 1, 2, 3, 6, and 12 recycles for the MPNN monomer sequences,
see Figure S7D. The success rate monotonically increases suggesting that more powerful
single sequence structure prediction models might have even higher success rates, i.e.
MPNN sequences are correctly encoding structures, but it is hard to predict those structures
using only single sequence information. Finally, we looked at the dependence between
AlphaFold pLDDT and true lDDT-CŒ±, i.e. between native target backbone for MPNN and
predicted AlphaFold backbone, Figure S8. The correlation is very much like in the original
AlphaFold paper (10) in this single sequence regime with slight underestimation of lDDT-CŒ±.
CŒ±-only ProteinMPNN
We trained ProteinMPNN which used CŒ± coordinates only as an input instead of full
backbone coordinates to have a way to generate sequences for coarse, or approximately
correct backbones. In the similar way as for the full atom ProteinMPNN adding inter-atom
6

distances as edge features helped to improve model‚Äôs performance. We added distances
between triplets of CŒ± atoms: CŒ±i-1, CŒ±i, CŒ±i and CŒ±j-1, CŒ±j, CŒ±j for residues i and j encoded
as 16 Gaussian radial basis functions. The rest of the architecture is the same as for the full
atom version. Sequence recovery and relative AlphaFold success rate as a function of
training noise level are shown in Figure S9.

Effects of training with Gaussian noise
We explored training sequence design models with additive Gaussian noise and found that
even very small amounts of noise (std=0.02 √Ö) decreased sequence recovery by almost 5%
(Figure 2C) suggesting that the model is able to pick up on crystallographic artefacts to
guess the correct amino acid identity. Adding higher levels of noise further decreases
sequence recovery, but interestingly increases AlphaFold success rate (Figure 2C). We
looked into sequence similarity to the consensus sequence generated by collecting multiple
sequence alignments for the native sequences. We found that a sequence similarly to the
consensus sequence is less sensitive to the training noise level compared with the sequence
similarity to the native backbone sequence (Figure S10A). Furthermore, we generated 128
sequences per target (sampling temperature 0.1) using ProteinMPNN and calculated
empirical probabilities for amino acids at every position (also known as 1D statistics, or
PSSM). We measured similarity between multiple sequence alignment PSSM and
ProteinMPNN empirical PSSM using Jensen-Shannon divergence and found that sequences
generated with the model which was trained with std=0.30 √Ö noise had the closest match
(Figure S10B) suggesting that ProteinMPNN models trained with some noise were sampling
more family like sequences. Users of ProteinMPNN can choose which models to use
depending on the quality of their input backbones.

Effects of sampling temperature
To model probabilities of amino acids given protein backbone coordinates we fit categorical
20

distributions defined by ùëù(ùê¥ùê¥|ùë†ùë°ùëüùë¢ùëêùë°ùë¢ùëüùëí) = ùëíùë•ùëù(ùëôùëúùëîùëñùë°ùë†/ùëá)/ ‚àë ùëíùë•ùëù(ùëôùëúùëîùëñùë°ùë†ùëñ/ùëá) where ùëôùëúùëîùëñùë°ùë†
ùëñ=1

are the outputs of the model (unnormalized probability) and ùëá is the sampling temperature
which is a hyperparameter which can be chosen at inference time. Low temperature would
lead to very sharp distributions whereas very high temperature would lead to uniform
distribution. During training the temperature is set to one. This means that sequence
7

recovery and generated sequence diversity will depend on the sampling temperature.
Sequence recovery decreases, but sequence diversity increases with higher temperatures
(Figure 2D). Same as for the sequence recovery (Figure 2A), the sequence diversity for
specific amino acids very much depends on the average distances of the neighboring
residue CŒ≤s (Figure S11B) - more conservation in the core and more diversity on the
surface. For a chosen example (PDB ID: 1QLG) we generated 32 sequence samples at
temperatures T=0.1; T=0.3 and plotted sequence similarity across all sequences (Figure
S11C, D). Average sequence recovery at T=0.1 and T=0.3 was 56.9% and 56.4%
accordingly. At the expense of the small sequence recovery decrease samples generated at
higher temperature have more diversity.
Experimental methods
HALC1_878 (PDB ID: 8CYK) (Figure 1D) was expressed in TBM-5052 medium with 50
Œºg/mL Kanamycin for 24 hours at 37¬∞C with shaking at 225 rpm using the autoinduction
method before harvesting via centrifugation at 4000xg for 5 minutes. Cells were lysed in
30ml of wash buffer (20 mM Tris, 300 mM NaCl, 25 mM Imidazole, pH 8.0) with sonication at
4¬∞C. Lysates were then centrifuged for 45 minutes at 14000xg and applied to Ni-NTA resin
that was pre-equilibrated with wash buffer. The resin was washed with 30 column volumes of
wash buffer. 6xhis affinity tags were removed via on-bead SNAC (29) cleavage. Resin was
washed with 20CV of cleavage buffer (100 mM CHES, 100 mM Acetone oxime, 100 mM
NaCl, pH 8.6) prior to incubation with 20ml cleavage buffer and 2mM NiCl‚ÇÇ overnight at room
temperature. Flow through was collected and concentrated to 1ml using 3K protein
concentrators (Millipore Sigma) before size exclusion chromatography using an S75 10/300
GL increase column (GE Healthcare).
HALC1_878 (PDB ID: 8CYK) was crystallized through sitting drop vapour diffusion at room
temperature in 0.1M citric acid pH 3.5 and 3M sodium chloride. Prior to harvesting and flash
freezing in liquid nitrogen, crystals were transferred to the crystallization condition with 25%
ethylene glycol. Diffraction data was collected at 100K at the Advanced Light Source
beamline 8.2.1. Images were integrated using XDS 20220110 (30), with Aimless (31) used
for scaling and merging. The design model was used as the search model for molecular
replacement with Phaser 2.8. (32) Model building and refinement was done using Coot 0.9.8
(33), and Phenix refine from Phenix 1.20. (34) All structures were validated using MolProbity
4.5.1. (35) Crystallographic statistics are available in Table S1. Crystallographic data has
been deposited to the protein bank with the PDB ID: 8CYK.

8

Protein sequences, expression and purification relating to the SH3 binder designs
All genes were cloned into pET-29b+. The plasmids were transformed into BL21 (DE3) E.
coli (NEB), and then expressed using autoinduction media (Studiers M2) with 200 ug/mL
kanamycin. After overnight (~18 hours) shaking at 37¬∞C, the cells were harvested and
centrifuged at 4000g for 15 minutes. The cell pellets were resuspended in Tris Buffer Saline
(25 mM Tris HCl pH 8, 150 mM NaCl, 10 mM imidazole, 50ug/mL DNase, 50ug/mL RNase,
as well as protease inhibitor tablet from Thermo Scientific Pierce). The suspended cells were
lysed by sonication, and then clarified by centrifuge at ~14,000g for 30 minutes. The
supernatant was subjected to Ni-NTA resin (Qiagen), and washed by high-salt Tris buffer (25
mM Tris HCl pH 8, 1000 mM NaCl, 25 mM imidazole), followed by regular Tris buffer (25 mM
Tris HCl pH 8, 150 mM NaCl, 25 mM imidazole). The protein of interest was then eluted by
elution buffer (25 mM Tris HCl pH 8, 150 mM NaCl, 400 mM imidazole). The protein was
dialyzed in PBS (pH 7.4) to remove imidazole. For the purification of the biotinylated Grb2
SH3 domain, a pBirA plasmid was co-transformed to the BL21 (DE3) E coli, and 10 mM
biotin was added to the cell culture. The protein elute from the Ni-NTA resin was purified
through FPLC with size exclusion column using PBS (pH 7.4).
1) Native Gab2-peptide-sfGFP
AIAPPPRPPKPSQ is the residue 348-360 of human Gab2, and in Red.
The core SH3 binding motif is highlighted in Cyan. sfGFP is in Green.

MGGSGGSGGAIAPPPRPPKPSQGGSGGSGGKGEELFTGVVPILVELDGDVNGHKFSV
RGEGEGDATNGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFARYPDHMKQHDFFKS
AMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEY
NFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLLPDNHY
LSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDELYKGSLEHHHHHH
2) Old Rosetta Design of SH3 domain binder
Design sequence is in Red. The core SH3 binding motif is highlighted in Cyan.
sfGFP is in Green.

MPKLDKIKEIVKKIKKLVESAASSGDKDKVVKVAWKALQALWEALIELLGGQLPPPR
PPKPGTDNLDKVVKQLAEAVKKAADEAKKAYPSKKVDEVVKAIKDVVDVIQEAVKTG
GSGGSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLP
VPWPTLVTTLTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGTYKTRAE
VKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIR
HNVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKRDHMVLLEFVT
AAGITHGMDELYKGSLEHHHHHH
9

3) The working ProteinMPNN design of SH3 domain binder
Design sequence is in Red. The core SH3 binding motif is highlighted in Cyan.
sfGFP is in Green. The key Asn residues are highlighted in Yellow.

MELAKKAIKKVEEIKKKVEAAAATGDRERIREVAYEALQEIHELINELLGGKFPPPR
PPKKGDEEKRRNVLENAERVKKYSEEVVKANPSEESKELVEAINKVVELVIEAVESG
GSGGSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLP
VPWPTLVTTLTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGTYKTRAE
VKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIR
HNVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKRDHMVLLEFVT
AAGITHGMDELYKGSLEHHHHHH
4) The D to N mutant of the working ProteinMPNN design of SH3 domain binder
Design sequence is in Red. The core SH3 binding motif is highlighted in Cyan.
sfGFP is in Green. The Asn to Asp mutations are highlighted in Yellow.

MELAKKAIKKVEEIKKKVEAAAATGDRERIREVAYEALQEIHELIDELLGGKFPPPR
PPKKGDEEKRRNVLEDAERVKKYSEEVVKANPSEESKELVEAINKVVELVIEAVESG
GSGGSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLP
VPWPTLVTTLTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGTYKTRAE
VKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIR
HNVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKRDHMVLLEFVT
AAGITHGMDELYKGSLEHHHHHH
5) Human Grb2 C-terminal SH3 with AviTag
The C-terminal SH3 of Grb2 sequence in Red
The AviTag is in Green.

MGGSGGPTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRN
YVTAVNGGSGGLNDIFEAQKIEWHEGGSGGHHHHHH
Biolayer Interferometry for SH3 binder designs
Octet RED96 (Sartorius, formerly ForteBio) was used for checking the SH3 domain binding
abilities. The biotinylated human Grb2 C-terminal SH3 was loaded to Octet SA Biosensors
(streptavidin-coated biosensors) at 50 nM concentration in Octet buffer (10 mM HEPES pH
7.4, 150 mM NaCl, 3 mM EDTA, 0.05% surfactant P20, 1% BSA). The proteins of interest

10

were diluted to planned concentration series using Octet Buffer. The binding curves
(association steps) were recorded after dipping the biosensors into the wells containing
proteins of interest with desired concentrations. The dissociation steps started when dipping
the biosensors into Octet Buffer.
Some details of using AlphaFold to judge ProteinMPNN designed SH3 binders
From the old Rosetta designed scaffold, we used proteinMPNN to generate 16 sequences.
Then we use Alphafold2 to generate 5 predicted models for each of the sequences. The
average pLDDT values of the 80 AlphaFold2 predictions have a mean of 85.45, with a
maximum of 90.60 and a minimum of 74.43.
In comparison, if we use AlphaFold2 to predict the original designed sequence (before
proteinMPNN refinement), the resulting 5 models' average pLDDT values are 82.93, 80.84,
74.65, 82.08, 83.98.
Below are top 5 models with the highest pLDDT values:
ProteinMPNN sequence #5, model #3, with average pLDDT value: 90.60
ProteinMPNN sequence #7, model #3, with average pLDDT value: 90.43
ProteinMPNN sequence #7, model #1, with average pLDDT value: 89.83
ProteinMPNN sequence #1, model #3, with average pLDDT value: 89.81
ProteinMPNN sequence #7, model #2, with average pLDDT value: 89.71
So for this scaffold, we chose and ordered 3 unique ProteinMPNN refined sequences (#5,
#7, #1). #7 and #1 didn't show any binding using yeast display screening, while sequence #5
showed decent binding, and we carried out Octet assays for #5 to further analyze its SH3
binding ability.
In brief, one original design -> 16 ProteinMPNN sequence -> 80 AlphaFold2 models -> order
3 sequences with top average LDDT -> 1 works
Unlike the above-mentioned original Rosetta design, which we carried out a decent amount
of characterization, we also chose 4 old designed models, which were never experimentally
characterized, and generated 64 ProteinMPNN designs. Again, by using AlphaFold2, we
selected 8 sequences (1 old design + 7 ProteinMPNN design) with average LDDT from
92.15 to 95.03. Unfortunately, none of these designs showed binding signals during yeast
display screening, and we didn't carry out further characterization.

11

When these sequences were ordered, AlphaFold-Multimer had not been released. So the
pLDDT values used for selecting sequences to order, only reflect the prediction confidence
of the designed binders. That might be the reason that the pLDDT values we were using are
not so discriminative. Developing metrics to select ProteinMPNN results for testing is very
critical, and hopefully with more experimental data and improving in silico prediction tools,
we can find more reliable metrics.

Fig. S1. In silico validation results. (A) Sequence recovery as a function of the number of
nearest neighbors in the graph. (B) Sequence recovery as a function of burial for monomers,
homomers, and heteromers. (C) Comparing three different ways of generating sequences
for homomers: unconstrained (treating as non-symmetric), averaging predicted probabilities,
averaging predicted logits (unnormalized probabilities). (D) An example showing negative
logits predicted by the model for chain A and chain B in the homodimer. The blue curve
shows averaged logits which will be normalized to sample an amino acid.

12

Fig. S2. Difference in compositional bias for Rosetta and ProteinMPNN. (A) Bias for all
residues in the monomer chain. (B) Bias for surface residues. (C) Bias for boundary
residues. (D) Bias for core residues.

13

Fig. S3. Sequence recovery dependence on confidence and backbone quality. (A) We
generated 32 sequences for every backbone in the test set of 690 PDB monomers using
sampling temperatures 0.1, 0.3, 0.5 and ranked them using the log probability of the model
(confidence). (B) Sequence recovery as a function of PDB resolution using 0.02 √Ö noised
MPNN model for a set of 690 PDB monomers. The black line shows a least squares linear
fit. Spearman's rank correlation was -0.487. (C) Sequence recovery as a function of
AlphaFold model confidence (average pLDDT) for a set of 1621 UniRef50 models.
Spearman's rank correlation was 0.489. (D) Training and validation perplexities as a function
of optimizer steps for different levels of backbone noise. Backbone noise and dropout (0.1)
was not applied during the validation.

14

Fig. S4. Size exclusion chromatography of ProteinMPNN designed two-component
tetrahedron nanoparticles. 13/76 nanoparticle designs eluted at ~13 mL on a Superdex
S200 10/300 Increase column, corresponding to nanoparticles of ~1 MDa. On the y-axis is
normalized absorbance (uv 230), on the x-axis is retention volume [mL].

Fig. S5. Designed backbone and crystal structure comparison. Target backbone
HALC1_878 (PDB ID: 8CYK) from hallucination on the left, AlphaFold prediction using
ProteinMPNN sequence in the middle, and crystal structure on the right (deposited to PDB
as 8CYK). Backbone RMSDs are shown for every pair of backbones.

15

Fig. S6. ProteinMPNN bias for different sampling temperatures. (A) ProteinMPNN
generates more charged amino acids in expense of the polar ones at low temperatures
which likely leads to highly thermo-stable proteins. (B) Amino acid bias is very small at
temperature T=1.0.

Fig. S7. Sequence recovery and AlphaFold (AF) benchmarks for the ProteinMPNN
trained with 0.2√Ö noise level. (A) Sequence recovery and AF success rate for monomeric
structures with true LDDT>95.0, 90.0 as a function of noise applied to backbones during the
inference, 1.0 corresponds to 3.3% absolute rate for 95.0 LDDT cutoff and to 16.0% for 90.0
cutoff. (B) Same as A, but as a function of sequence sampling temperature, 1.0 corresponds
to 3.3% absolute rate for 95.0 LDDT cutoff and to 16.5% for 90.0 cutoff. (C) Sequence
recovery and AF success rate for homomers with inter-chain PAE<4.0, 6.0 as a function of
training noise level, 1.0 corresponds to 2.4% for the 4.0 PAE cutoff, and to 5.6% for the 6.0
cutoff. (D) AlphaFold success rate as a function of number of AlphaFold recycles for
monomers.
16

Fig. S8. Comparing true lDDT-CŒ± with AlphaFold predicted pLDDT for MPNN sequence
redesigns on native PDB backbone monomers using single sequence prediction.
lDDT-CŒ± is calculated between the native backbone input to the MPNN and the AlphaFold
output using MPNN sequence. (A) pLDDT and lDDT-CŒ± are highly correlated in this regime.
(B) Zoomed in version of A showing that true lDDT-CŒ± is slightly underestimated by pLDDT.

Fig. S9. Benchmarks of CŒ±-only ProteinMPNN model for monomers. (A) Sequence
recovery as a function of training noise level for CŒ±-only and full backbone models. (B)
Relative AlphaFold success rate as a function of training noise level for CŒ±-only and full
backbone networks for the models with lDDT-CŒ±>90.0, 1.0 is equal to 6.7% success rate.

17

Fig. S10. Sequence comparison against consensus and PSSM distributions

(A)

Sequence similarity with respect to native and consensus sequences as a function of
training noise level using sampling temperature of 0.1. Similarity to the consensus sequence
is less sensitive to the training noise. (B) Sequence recovery and similarity to PSSM defined
as one minus ‚ÄãJensen-Shannon divergence between PSSM distribution from multiple
sequence alignment (up to 90% sequence identity cutoff)

and empirical ProteinMPNN

distribution for 128 generated sequences.

18

Fig. S11. Further analysis. (A) Comparing ProteinMPNN scores (average negative log
likelihoods) for AlphaFold hallucinated and ProteinMPNN redesigned sequences for the
same backbones. Colors indicate if expressed sequences were soluble from both methods,
only from ProteinMPNN, only from AlphaFold, or none of them were soluble. (B) Sequence
similarity from a sample of 32 sequences to each other as a function of residue burial for
temperatures T=0.1, T=0.3, and T=0.5. Increasing sampling temperature mostly affects
surface residues. (C, D) An example showing sequence similarities across 32 ProteinMPNN
samples for a protein backbone of 1QLG at temperatures T=0.1; T=0.3.

19

Fig. S12. ProteinMPNN sequences recoveries. Scatter plot showing sequence recovery
for Rosetta vs. ProteinMPNN for 402 monomer backbones. Average sequence recovery for
ProteinMPNN was 52.4%, compared to 32.9% for Rosetta. There is a clear correlation
between two methods.

20

HALC1_878 (PDB ID:
8CYK)
Data Collection
Space group

I121

Cell dimensions
a, b, c (√Ö)

64.17, 55.45, 82.81

Œ±, Œ≤, Œ≥ (¬∞)

90.00, 94.00, 90.00

Resolution (√Ö)

48.98 - 1.65 (1.709 1.65)

Rmerge (%)

2.1 (19.4)

Rpim (%)

2.1 (19.4)

/œÉ(I)

15.91 (3.96)

CC 1/2

0.999 (0.942)

Completeness (%)

96.85 (95.70)

Redundancy

2.0 (2.0)

Refinement
No. unique reflections

33946 (3322)

Rwork / Rfree (%)

18.5 (24.0) / 21.7
(28.1)

No. non-hydrogen atoms

2366

Macromolecules

2151

Water

215

Ramachandran
favoured/allowed

98.83/1.17

R.m.s. deviations
Bond lengths (√Ö)

0.011

Bond angles (¬∞)

1.12

B-factors (√Ö2)
Macromolecules

28.36

Solvent

39.25

Table S1. Crystallographic statistics for HALC1_878.

21

References and Notes
1. J. Ingraham, V. K. Garg, R. Barzilay, T. Jaakkola, ‚ÄúGenerative models for graph-based
protein design‚Äù in Advances in Neural Information Processing Systems 32 (NeurIPS
2019), H. Wallach, H. Larochelle, A. Beygelzimer, F. d‚ÄôAlch√©-Buc, E. Fox, R.
Garnett, Eds. (Neural Information Processing Systems Foundation, 2019), pp. 15741‚Äì
15752.
2. Y. Zhang, Y. Chen, C. Wang, C. C. Lo, X. Liu, W. Wu, J. Zhang, ProDCoNN: Protein
design using a convolutional neural network. Proteins 88, 819‚Äì829 (2020).
doi:10.1002/prot.25868 Medline
3. Y. Qi, J. Z. H. Zhang, DenseCPD: Improving the accuracy of neural-network-based
computational protein sequence design with DenseNet. J. Chem. Inf. Model. 60,
1245‚Äì1252 (2020). doi:10.1021/acs.jcim.0c00043 Medline
4. B. Jing, S. Eismann, P. Suriana, R. J. L. Townshend, R. Dror, ‚ÄúLearning from protein
structure with geometric vector perceptrons,‚Äù paper presented at the International
Conference on Learning Representations, Vienna, Austria, 4 May 2021.
5. A. Strokach, D. Becerra, C. Corbi-Verge, A. Perez-Riba, P. M. Kim, Fast and flexible
protein design using deep graph neural networks. Cell Syst. 11, 402‚Äì411.e4 (2020).
doi:10.1016/j.cels.2020.08.016 Medline
6. N. Anand, R. Eguchi, I. I. Mathews, C. P. Perez, A. Derry, R. B. Altman, P. S. Huang,
Protein sequence design with a learned potential. Nat. Commun. 13, 746 (2022).
doi:10.1038/s41467-022-28313-9 Medline
7. C. Hsu, R. Verkuil, J. Liu, Z. Lin, B. Hie, T. Sercu, A. Lerer, A. Rives, Learning inverse
folding from millions of predicted structures. bioRxiv 2022.04.10.487779 [Preprint]
(2022); https://doi.org/10.1101/2022.04.10.487779.
8. C. A. Orengo, A. D. Michie, S. Jones, D. T. Jones, M. B. Swindells, J. M. Thornton,
CATH‚ÄîA hierarchic classification of protein domain structures. Structure 5, 1093‚Äì
1108 (1997). doi:10.1016/S0969-2126(97)00260-8 Medline
9. B. Uria, I. Murray, H. Larochelle, ‚ÄúA deep and tractable density estimator‚Äù in Proceedings
of the 31st International Conference on Machine Learning, E. P. Xing, T. Jebara, Eds.
(JMLR, 2014), pp. 467‚Äì475.
10. J. Jumper, R. Evans, A. Pritzel, T. Green, M. Figurnov, O. Ronneberger, K.
Tunyasuvunakool, R. Bates, A. ≈Ω√≠dek, A. Potapenko, A. Bridgland, C. Meyer, S. A.
A. Kohl, A. J. Ballard, A. Cowie, B. Romera-Paredes, S. Nikolov, R. Jain, J. Adler, T.
Back, S. Petersen, D. Reiman, E. Clancy, M. Zielinski, M. Steinegger, M. Pacholska,
T. Berghammer, S. Bodenstein, D. Silver, O. Vinyals, A. W. Senior, K. Kavukcuoglu,
P. Kohli, D. Hassabis, Highly accurate protein structure prediction with AlphaFold.
Nature 596, 583‚Äì589 (2021). doi:10.1038/s41586-021-03819-2 Medline
11. A. Leaver-Fay, M. J. O‚ÄôMeara, M. Tyka, R. Jacak, Y. Song, E. H. Kellogg, J. Thompson,
I. W. Davis, R. A. Pache, S. Lyskov, J. J. Gray, T. Kortemme, J. S. Richardson, J. J.
Havranek, J. Snoeyink, D. Baker, B. Kuhlman, Scientific benchmarks for guiding
macromolecular energy function improvement. Methods Enzymol. 523, 109‚Äì143
(2013). doi:10.1016/B978-0-12-394292-0.00006-0 Medline
12. J. K. Leman, B. D. Weitzner, S. M. Lewis, J. Adolf-Bryfogle, N. Alam, R. F. Alford, M.
Aprahamian, D. Baker, K. A. Barlow, P. Barth, B. Basanta, B. J. Bender, K.

Blacklock, J. Bonet, S. E. Boyken, P. Bradley, C. Bystroff, P. Conway, S. Cooper, B.
E. Correia, B. Coventry, R. Das, R. M. De Jong, F. DiMaio, L. Dsilva, R. Dunbrack,
A. S. Ford, B. Frenz, D. Y. Fu, C. Geniesse, L. Goldschmidt, R. Gowthaman, J. J.
Gray, D. Gront, S. Guffy, S. Horowitz, P.-S. Huang, T. Huber, T. M. Jacobs, J. R.
Jeliazkov, D. K. Johnson, K. Kappel, J. Karanicolas, H. Khakzad, K. R. Khar, S. D.
Khare, F. Khatib, A. Khramushin, I. C. King, R. Kleffner, B. Koepnick, T.
Kortemme, G. Kuenze, B. Kuhlman, D. Kuroda, J. W. Labonte, J. K. Lai, G.
Lapidoth, A. Leaver-Fay, S. Lindert, T. Linsky, N. London, J. H. Lubin, S. Lyskov, J.
Maguire, L. Malmstr√∂m, E. Marcos, O. Marcu, N. A. Marze, J. Meiler, R. Moretti, V.
K. Mulligan, S. Nerli, C. Norn, S. √ì‚ÄôConch√∫ir, N. Ollikainen, S. Ovchinnikov, M. S.
Pacella, X. Pan, H. Park, R. E. Pavlovicz, M. Pethe, B. G. Pierce, K. B. Pilla, B.
Raveh, P. D. Renfrew, S. S. R. Burman, A. Rubenstein, M. F. Sauer, A. Scheck, W.
Schief, O. Schueler-Furman, Y. Sedan, A. M. Sevy, N. G. Sgourakis, L. Shi, J. B.
Siegel, D.-A. Silva, S. Smith, Y. Song, A. Stein, M. Szegedy, F. D. Teets, S. B.
Thyme, R. Y.-R. Wang, A. Watkins, L. Zimmerman, R. Bonneau, Macromolecular
modeling and design in Rosetta: Recent methods and frameworks. Nat. Methods 17,
665‚Äì680 (2020). doi:10.1038/s41592-020-0848-2 Medline
13. M. Baek, F. DiMaio, I. Anishchenko, J. Dauparas, S. Ovchinnikov, G. R. Lee, J. Wang,
Q. Cong, L. N. Kinch, R. D. Schaeffer, C. Mill√°n, H. Park, C. Adams, C. R.
Glassman, A. DeGiovanni, J. H. Pereira, A. V. Rodrigues, A. A. van Dijk, A. C.
Ebrecht, D. J. Opperman, T. Sagmeister, C. Buhlheller, T. Pavkov-Keller, M. K.
Rathinaswamy, U. Dalwadi, C. K. Yip, J. E. Burke, K. C. Garcia, N. V. Grishin, P. D.
Adams, R. J. Read, D. Baker, Accurate prediction of protein structures and
interactions using a three-track neural network. Science 373, 871‚Äì876 (2021).
doi:10.1126/science.abj8754 Medline
14. V. Mariani, M. Biasini, A. Barbato, T. Schwede, lDDT: A local superposition-free score
for comparing protein structures and models using distance difference tests.
Bioinformatics 29, 2722‚Äì2728 (2013). doi:10.1093/bioinformatics/btt473 Medline
15. B. I. M. Wicky, L. F. Milles, A. Courbet, R. J. Ragotte, J. Dauparas, E. Kinfu, S. Tipps,
R. D. Kibler, M. Baek, F. DiMaio, X. Li, L. Carter, A. Kang, H. Nguyen, A. K. Bera,
D. Baker, Hallucinating symmetric protein assemblies. Science 378, 56‚Äì61 (2022).
doi:10.1126/science.add1964
16. N. P. King, J. B. Bale, W. Sheffler, D. E. McNamara, S. Gonen, T. Gonen, T. O. Yeates,
D. Baker, Accurate design of co-assembling multi-component protein nanomaterials.
Nature 510, 103‚Äì108 (2014). doi:10.1038/nature13404 Medline
17. S. Boyoglu-Barnum, D. Ellis, R. A. Gillespie, G. B. Hutchinson, Y.-J. Park, S. M. Moin,
O. J. Acton, R. Ravichandran, M. Murphy, D. Pettie, N. Matheson, L. Carter, A.
Creanga, M. J. Watson, S. Kephart, S. Ataca, J. R. Vaile, G. Ueda, M. C. Crank, L.
Stewart, K. K. Lee, M. Guttman, D. Baker, J. R. Mascola, D. Veesler, B. S. Graham,
N. P. King, M. Kanekiyo, Quadrivalent influenza nanoparticle vaccines induce broad
protection. Nature 592, 623‚Äì628 (2021). doi:10.1038/s41586-021-03365-x Medline
18. A. C. Walls, B. Fiala, A. Sch√§fer, S. Wrenn, M. N. Pham, M. Murphy, L. V. Tse, L.
Shehata, M. A. O‚ÄôConnor, C. Chen, M. J. Navarro, M. C. Miranda, D. Pettie, R.
Ravichandran, J. C. Kraft, C. Ogohara, A. Palser, S. Chalk, E.-C. Lee, K. Guerriero,
E. Kepl, C. M. Chow, C. Sydeman, E. A. Hodge, B. Brown, J. T. Fuller, K. H. Dinnon
III, L. E. Gralinski, S. R. Leist, K. L. Gully, T. B. Lewis, M. Guttman, H. Y. Chu, K.
K. Lee, D. H. Fuller, R. S. Baric, P. Kellam, L. Carter, M. Pepper, T. P. Sheahan, D.

Veesler, N. P. King, Elicitation of potent neutralizing antibody responses by designed
protein nanoparticle vaccines for SARS-CoV-2. Cell 183, 1367‚Äì1382.e17 (2020).
doi:10.1016/j.cell.2020.10.043 Medline
19. J. Marcandalli, B. Fiala, S. Ols, M. Perotti, W. de van der Schueren, J. Snijder, E. Hodge,
M. Benhaim, R. Ravichandran, L. Carter, W. Sheffler, L. Brunner, M. Lawrenz, P.
Dubois, A. Lanzavecchia, F. Sallusto, K. K. Lee, D. Veesler, C. E. Correnti, L. J.
Stewart, D. Baker, K. Lor√©, L. Perez, N. P. King, Induction of potent neutralizing
antibody responses by a designed protein nanoparticle vaccine for respiratory
syncytial virus. Cell 176, 1420‚Äì1431.e17 (2019). doi:10.1016/j.cell.2019.01.046
Medline
20. L. Cao, B. Coventry, I. Goreshnik, B. Huang, W. Sheffler, J. S. Park, K. M. Jude, I.
Markoviƒá, R. U. Kadam, K. H. G. Verschueren, K. Verstraete, S. T. R. Walsh, N.
Bennett, A. Phal, A. Yang, L. Kozodoy, M. DeWitt, L. Picton, L. Miller, E.-M.
Strauch, N. D. DeBouver, A. Pires, A. K. Bera, S. Halabiya, B. Hammerson, W.
Yang, S. Bernard, L. Stewart, I. A. Wilson, H. Ruohola-Baker, J. Schlessinger, S.
Lee, S. N. Savvides, K. C. Garcia, D. Baker, Design of protein-binding proteins from
the target structure alone. Nature 605, 551‚Äì560 (2022). doi:10.1038/s41586-02204654-9 Medline
21. J. Dauparas, S. O, S. Duerr, dauparas/ProteinMPNN: ProteinMPNN (v1.0.0). Zenodo
(2022); https://doi.org/10.5281/zenodo.6941302.
22. A. Vaswani, N. Shazeer, N. Parmar, J. Uszkoreit, L. Jones, A. N. Gomez, L. Kaiser, I.
Polosukhin, ‚ÄúAttention is all you need‚Äù in Advances in Neural Information Processing
Systems 30 (NeurIPS 2017), I. Guyon, U. Von Luxburg, S. Bengio, H. Wallach, R.
Fergus, S. Vishwanathan, R. Garnett, Eds. (Neural Information Processing Systems
Foundation, 2017), pp. 5999‚Äì6009.
23. N. Srivastava, G. Hinton, A. Krizhevsky, I. Sutskever, R. Salakhutdinov, Dropout: A
simple way to prevent neural networks from overfitting. J. Mach. Learn. Res. 15,
1929‚Äì1958 (2014).
24. C. Szegedy, V. Vanhoucke, S. Ioffe, J. Shlens, Z. Wojna, ‚ÄúRethinking the inception
architecture for computer vision‚Äù in Proceedings of the IEEE Conference on
Computer Vision and Pattern Recognition (IEEE, 2016), pp. 2818‚Äì2826.
25. M. Steinegger, J. S√∂ding, MMseqs2 enables sensitive protein sequence searching for the
analysis of massive data sets. Nat. Biotechnol. 35, 1026‚Äì1028 (2017).
doi:10.1038/nbt.3988 Medline
26. Y. Zhang, J. Skolnick, TM-align: A protein structure alignment algorithm based on the
TM-score. Nucleic Acids Res. 33, 2302‚Äì2309 (2005). doi:10.1093/nar/gki524 Medline
27. A. Paszke, S. Gross, F. Massa, A. Lerer, J. Bradbury, G. Chanan, T. Killeen, Z. Lin, N.
Gimelshein, L. Antiga, A. Desmaison, A. Kopf, E. Yang, Z. Devito, M. Raison, A.
Tejani, S. Chilamkurth, ‚ÄúPytorch: An imperative style, high-performance deep
learning library‚Äù in Advances in Neural Information Processing Systems 32 (NeurIPS
2019), H. Wallach, H. Larochelle, A. Beygelzimer, F. d‚ÄôAlch√©-Buc, E. Fox, R.
Garnett, Eds. (Neural Information Processing Systems Foundation, 2019), pp. 7994‚Äì
8005.
28. J. Gilmer, S. S. Schoenholz, P. F. Riley, O. Vinyals, G. E. Dahl, ‚ÄúNeural message passing
for quantum chemistry‚Äù in Proceedings of the 34th International Conference on
Machine Learning, D. Precup, Y. W. The, Eds. (JMLR, 2017), pp. 1263‚Äì1272.

29. B. Dang, M. Mravic, H. Hu, N. Schmidt, B. Mensa, W. F. DeGrado, SNAC-tag for
sequence-specific chemical protein cleavage. Nat. Methods 16, 319‚Äì322 (2019).
doi:10.1038/s41592-019-0357-3 Medline
30. W. Kabsch, XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125‚Äì132 (2010).
doi:10.1107/S0907444909047337 Medline
31. M. D. Winn, C. C. Ballard, K. D. Cowtan, E. J. Dodson, P. Emsley, P. R. Evans, R. M.
Keegan, E. B. Krissinel, A. G. W. Leslie, A. McCoy, S. J. McNicholas, G. N.
Murshudov, N. S. Pannu, E. A. Potterton, H. R. Powell, R. J. Read, A. Vagin, K. S.
Wilson, Overview of the CCP4 suite and current developments. Acta Crystallogr. D
Biol. Crystallogr. 67, 235‚Äì242 (2011). doi:10.1107/S0907444910045749 Medline
32. A. J. McCoy, R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, R. J.
Read, Phaser crystallographic software. J. Appl. Crystallogr. 40, 658‚Äì674 (2007).
doi:10.1107/S0021889807021206 Medline
33. P. Emsley, K. Cowtan, Coot: Model-building tools for molecular graphics. Acta
Crystallogr. D Biol. Crystallogr. 60, 2126‚Äì2132 (2004).
doi:10.1107/S0907444904019158 Medline
34. P. D. Adams, P. V. Afonine, G. Bunk√≥czi, V. B. Chen, I. W. Davis, N. Echols, J. J.
Headd, L.-W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W.
Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C.
Terwilliger, P. H. Zwart, PHENIX: A comprehensive Python-based system for
macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213‚Äì
221 (2010). doi:10.1107/S0907444909052925 Medline
35. C. J. Williams, J. J. Headd, N. W. Moriarty, M. G. Prisant, L. L. Videau, L. N. Deis, V.
Verma, D. A. Keedy, B. J. Hintze, V. B. Chen, S. Jain, S. M. Lewis, W. B. Arendall
III, J. Snoeyink, P. D. Adams, S. C. Lovell, J. S. Richardson, D. C. Richardson,
MolProbity: More and better reference data for improved all-atom structure
validation. Protein Sci. 27, 293‚Äì315 (2018). doi:10.1002/pro.3330 Medline

